BioLife Solutions Inc (BLFS) CEO Sells $69,847.80 in Stock

BioLife Solutions Inc (NASDAQ:BLFS) CEO Michael Rice sold 12,540 shares of the stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $5.57, for a total transaction of $69,847.80. Following the transaction, the chief executive officer now owns 152,057 shares in the company, valued at $846,957.49. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Shares of BioLife Solutions Inc (BLFS) opened at $5.62 on Friday. The stock has a market cap of $80.48, a P/E ratio of -13.38 and a beta of 0.27. BioLife Solutions Inc has a 1 year low of $1.71 and a 1 year high of $7.53.

BioLife Solutions (NASDAQ:BLFS) last posted its earnings results on Thursday, November 9th. The medical equipment provider reported ($0.03) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.06) by $0.03. The firm had revenue of $2.96 million during the quarter, compared to the consensus estimate of $2.60 million. BioLife Solutions had a negative net margin of 52.10% and a negative return on equity of 49.92%. research analysts anticipate that BioLife Solutions Inc will post -0.21 earnings per share for the current year.

Separately, Maxim Group set a $8.00 target price on shares of BioLife Solutions and gave the stock a “buy” rating in a research report on Thursday, January 4th.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Essex Investment Management Co. LLC acquired a new stake in BioLife Solutions during the 3rd quarter worth approximately $484,000. EAM Investors LLC acquired a new stake in BioLife Solutions during the 3rd quarter worth approximately $555,000. Finally, Granite Investment Partners LLC acquired a new stake in BioLife Solutions during the 3rd quarter worth approximately $1,205,000. 9.15% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at

About BioLife Solutions

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit